vimarsana.com

Latest Breaking News On - River pharmaceutical - Page 1 : vimarsana.com

Alvotech and Teva Announce U S Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® -February 23, 2024 at 08:16 pm EST

SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership.

Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04

REYKJAVIK, Iceland, Jan. 19, 2024 Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the.

Yangtze River Pharmaceutical (Group) Co , Ltd Won the 2021 EFQM Global Award

Share this article Share this article TAIZHOU, China, March 8, 2021 /PRNewswire/ At 19:20 on March 4, 2021 (Beijing time), the results of the 2021 EFQM Global Award were announced. Yangtze River Pharmaceutical (Group) Co., Ltd. from China was on the list, which represents that its quality management level has been aligned with that of world-class companies, and has won praises from the world for Made in China . Yangtze River Pharmaceutical (Group) Co., Ltd. Won the 2021 EFQM Global Award Applying for the EFQM Global Award is a fusion of Chinese culture and European culture, a bridge connecting Chinese quality and European quality, and a mutual learning between Chinese management model and EFQM model. We will continue to promote the application of the EFQM model to serve the health of all mankind, Mr. Xu Jingren, chairman of Yangtze River Pharmaceutical Group, said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.